| http://www.w3.org/ns/prov#value | - As reported in the Wall Street Journal Health Blog, an FDA advisory panel unanimously rejected Zimulti:By a unanimous vote, a panel of experts convened by the FDA just rejected Sanofi-Aventis's weight-loss drug, known in Europe as Acomplia, Dow Jones reports.The drug has been associated with psychiatric side effects including depression and an increased risk of suicidal thoughts.
|
